K Number
K980201
Device Name
DIO-LIGHT LASER SYSTEM
Manufacturer
Date Cleared
1998-03-16

(55 days)

Product Code
Regulation Number
878.4810
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Nidek Dio-Light Laser System is intended for all cleared Cynosure Photogenica LPIR applications. Treatment of vascular and pigmented lesions in Dermatology.
Device Description
Not Found
More Information

Not Found

No
The provided 510(k) summary does not contain any mention of AI, ML, image processing, or performance studies typically associated with AI/ML devices. The device description is also missing.

Yes
The device is described as treating "vascular and pigmented lesions in Dermatology," which indicates it is used for medical treatment.

No

Explanation: The Nidek Dio-Light Laser System is described as a treatment device for vascular and pigmented lesions, not a device used to diagnose medical conditions.

No

The device is described as a "Laser System," which inherently implies a hardware component for generating and delivering laser energy. The predicate device is also a "laser system." There is no mention of the device being solely software.

Based on the provided information, the Nidek Dio-Light Laser System is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use is for the "Treatment of vascular and pigmented lesions in Dermatology." This describes a therapeutic intervention performed directly on a patient, not a test performed on a sample taken from a patient to diagnose a condition.
  • Device Description: While the description is "Not Found," the intended use clearly points to a treatment device.
  • Lack of IVD Characteristics: The provided information does not mention any of the typical characteristics of an IVD, such as:
    • Analyzing biological samples (blood, urine, tissue, etc.)
    • Providing diagnostic information
    • Using reagents or assays

The Nidek Dio-Light Laser System appears to be a therapeutic laser system used for dermatological treatments.

N/A

Intended Use / Indications for Use

Nidek Dio-Light Laser System is intended for all cleared Cynosure Photogenica LPIR applications.

Treatment of vascular and pigmented lesions in Dermatology.

Product codes

GEX

Device Description

Not Found

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Cynosure's Photogenica LPIR laser system.

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.

0

K48020/

MAR 1 6 1998

SUMMARY OF SAFETY AND EFFECTIVENESS NIDEK PRIMA KTP SURGICAL LASER SYSTEM

REGULATORY AUTHORITY:

Safe Medical Devices Act of 1990, 21 CFR 807.92

COMPANY NAME/CONTACT:

Ken Kato Vice President 47651 Westinghouse Drive Fremont, CA 94539 Phone: (510) 226-5700 Fax: (510) 226-5750

DEVICE TRADE NAME:

Dio-Light Laser System

DEVICE COMMON NAME:

Laser Diode Surgical Laser System

DEVICE CLASSIFICATION:

Surgical laser systems are classified as Class II.

PERFORMANCE STANDARDS:

The laser systems manufactured by Nidek Inc. comply with 21 CFR 1040.10 and 1040.11, FDA regulations for medical laser products, as applicable.

INDICATIONS FOR USE STATEMENT:

Nidek Dio-Light Laser System is intended for all cleared Cynosure Photogenica LPIR applications.

1

COMPARISON WITH PREDICATE DEVICE:

The Nidek Dio-Light system is substantially equivalent to Cynosure's Photogenica LPIR laser system.

The risks and benefits of the Nidek Dio-Light are comparable to the predicate device when used for similar clinical applications.

Since the Nidek Dio-Light laser system is substantially equivalent with respect to indications for use, materials, method of operation and physical construction to the predicate device, we believe it clearly meets the requirement for substantial equivalence according to 510(k) guidelines. Safety and effectiveness are reasonably assured, therefore justifying 510(k) clearance for commercial sale.

2

Image /page/2/Picture/2 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the perimeter. Inside the circle is a stylized representation of a human figure, with three curved lines forming the body and head.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAR 1 6 1998

Mr. Ken Kato ·Vice President Nidek Incorporated 47651 Westinghouse Drive Fremont, California 94539

Re: K980201 Trade Name: Dio-Light Laser System Regulatory Class: II GEX Product Code: Dated: January 16, 1998 Received: January 20, 1998

Dear Mr. Kato:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. ದ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal Laws or regulations.

3

Page 2 - Mr. Kato

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

4

Page 1 of 1

510(k) Number (if known): __ K 9 Jo 201

Device Name: Nidek Dio-Light Laser System

Indications for Use: Treatment of vascular and pigmented lesions in Dermatology.

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of General Restorative Devices
510(k) NumberK980201

| Prescription Use

(Pér 21 CFR 801.109)OROver the Counter Use
--------------------------------------------------------------------